Multiplex N-terminome Analysis of MMP-2 and MMP-9 Substrate Degradomes by iTRAQ-TAILS Quantitative Proteomics

被引:218
作者
Prudova, Anna
Keller, Ulrich Auf Dem
Butler, Georgina S.
Overall, Christopher M. [1 ]
机构
[1] Univ British Columbia, Dept Biochem & Mol Biol, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
MATRIX-METALLOPROTEINASE INHIBITORS; TISSUE-GROWTH-FACTOR; GELATINASE-A; TUMOR-GROWTH; PROTEASE PROTEOMICS; PROTEOLYTIC EVENTS; CLEAVAGE SITES; CANCER-CELLS; IDENTIFICATION; BINDING;
D O I
10.1074/mcp.M000050-MCP201
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Proteolysis is a major protein posttranslational modification that, by altering protein structure, affects protein function and, by truncating the protein sequence, alters peptide signatures of proteins analyzed by proteomics. To identify such modified and shortened protease-generated neo-N-termini on a proteome-wide basis, we developed a whole protein isobaric tag for relative and absolute quantitation (iTRAQ) labeling method that simultaneously labels and blocks all primary amines including protein Ntermini and lysine side chains. Blocking lysines limits trypsin cleavage to arginine, which effectively elongates the proteolytically truncated peptides for improved MS/MS analysis and peptide identification. Incorporating iTRAQ whole protein labeling with terminal amine isotopic labeling of substrates (iTRAQ-TAILS) to enrich the N-terminome by negative selection of the blocked mature original N-termini and neo-N-termini has many advantages. It enables simultaneous characterization of the natural N-termini of proteins, their N-terminal modifications, and proteolysis product and cleavage site identification. Furthermore, iTRAQ-TAILS also enables multiplex N-terminomics analysis of up to eight samples and allows for quantification in MS2 mode, thus preventing an increase in spectral complexity and extending proteome coverage by signal amplification of low abundance proteins. We compared the substrate degradomes of two closely related matrix metalloproteinases, MMP-2 (gelatinase A) and MMP-9 (gelatinase B), in fibroblast secreted proteins. Among 3,152 unique N-terminal peptides identified corresponding to 1,054 proteins, we detected 201 cleavage products for MMP-2 and unexpectedly only 19 for the homologous MMP-9 under identical conditions. Novel substrates identified and biochemically validated include insulin-like growth factor binding protein-4, complement C1r component A, galectin-1, dickkopf-related protein-3, and thrombospondin-2. Hence, N-terminomics analyses using iTRAQ-TAILS links gelatinases with new mechanisms of action in angiogenesis and reveals unpredicted restrictions in substrate repertoires for these two very similar proteases. Molecular & Cellular Proteomics 9: 894- 911, 2010.
引用
收藏
页码:894 / 911
页数:18
相关论文
共 106 条
[11]   Mannose-binding lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis - Potential role in human MBL deficiency [J].
Butler, GS ;
Sim, D ;
Tam, E ;
Devine, D ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17511-17519
[12]   The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity - Probing the role of the methionine-turn in the metzincin metalloprotease superfamily [J].
Butler, GS ;
Tam, EM ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :15615-15620
[13]   Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates [J].
Cauwe, Benedicte ;
Martens, Erik ;
Proost, Paul ;
Opdenakker, Ghislain .
INTEGRATIVE BIOLOGY, 2009, 1 (5-6) :404-426
[14]   SUBTILIGASE - A TOOL FOR SEMISYNTHESIS OF PROTEINS [J].
CHANG, TK ;
JACKSON, DY ;
BURNIER, JP ;
WELLS, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12544-12548
[15]   Improved visualization of protein consensus sequences by iceLogo [J].
Colaert, Niklaas ;
Helsens, Kenny ;
Martens, Lennart ;
Vandekerckhove, Joel ;
Gevaert, Kris .
NATURE METHODS, 2009, 6 (11) :786-787
[16]   Matrix metalloprotease-3 and-9 proteolyze insulin-like growth factor-binding protein-1 [J].
Coppock, HA ;
White, A ;
Aplin, JD ;
Westwood, M .
BIOLOGY OF REPRODUCTION, 2004, 71 (02) :438-443
[17]   Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].
Coussens, LM ;
Fingleton, B ;
Matrisian, LM .
SCIENCE, 2002, 295 (5564) :2387-2392
[18]  
Cox Jennifer H., 2008, P519, DOI 10.1007/978-0-387-69057-5_26
[19]   Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens:: Disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis [J].
Dean, Richard A. ;
Butler, Georgina S. ;
Hamma-Kourbali, Yamina ;
Delbe, Jean ;
Brigstock, David R. ;
Courty, Jose ;
Overall, Christopher M. .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (24) :8454-8465
[20]   Proteornics discovery of metalloproteinase substrates in the cellular context by iTRAQTM labeling reveals a diverse MMP-2 substrate degradome [J].
Dean, Richard A. ;
Overall, Christopher M. .
MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (04) :611-623